Late-Life Depression

Chapter

Abstract

Depression is one of the most common psychiatric disorders experienced by the older adults. The misconception that feeling sad is part of normal aging contributes to the underdiagnosis and undertreatment of depression in the older population. According to the Diagnostic and Statistical Manual of Mental Disorders, 5th edition (DSM-5), the category depressive disorders includes disruptive mood dysregulation disorder, major depressive disorder, persistent depressive disorder, premenstrual dysphoric disorder, substance-/medication-induced depressive disorder, depressive disorder due to another medical condition, and other specified depressive disorders and unspecified depressive disorders. The term late-life depression includes both older adults who are presenting with depression for the first time later in life (known as late-onset depression) and aging patients whose depressive disorders initially presented in earlier life. The following chapter presents an overview of the symptomatology, evaluation, and treatment of depression in the older population.

Keywords

Late-life depression Late-onset depression Major depressive disorder Depression Antidepressant Pseudodementia 

References

  1. 1.
    American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 5th ed. Arlington: American Psychiatric Publishing; 2013. p. 155–88.CrossRefGoogle Scholar
  2. 2.
    Unützer J. Late-life depression. N Engl J Med. 2007;357:2269–76.CrossRefPubMedGoogle Scholar
  3. 3.
    Fiske A, Wetherell JL, Gatz M. Depression in older adults. Annu Rev Clin Psychol. 2009;5:363–89.CrossRefPubMedPubMedCentralGoogle Scholar
  4. 4.
    Patten SB, Williams JVA, Lavorato DH, et al. Descriptive epidemiology of major depressive disorder in Canada in 2012. Can J Psychiatry. 2015;60(1):23–30.Google Scholar
  5. 5.
    Andrade L, Caraveo-Anduaga JJ, Berglund P, et al. The epidemiology of major depressive episodes: results from the international consortium of psychiatric epidemiology (ICPE) surveys. Int J Methods Psychiatr Res. 2003;12(1):3–21.CrossRefPubMedGoogle Scholar
  6. 6.
    Valiengo L, Stella F, Forlenza OV. Mood disorders in the elderly: prevalence, functional impact, and management challenges. Neuropsychiatr Dis Treat. 2016;12:2105–14.CrossRefPubMedCentralGoogle Scholar
  7. 7.
    Dines P, Hu W, Sajatovic M. Depression in later-life: an overview of assessment and management. Psychiatr Danub. 2014;26(1):78–84.PubMedGoogle Scholar
  8. 8.
    Avari JN, Alexopoulos GS. Models of care for late-life depression of the medically ill: examples from COPD and stroke. Am J Geriatr Psychiatry. 2015;23(5):477–87.CrossRefPubMedGoogle Scholar
  9. 9.
    Lam RW, McIntosh D, Wang JL, et al. Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 clinical guidelines for the management of adults with major depressive disorder: section 1. Disease burden and principles of care. Can J Psychiatry. 2016;61(9):510–23.Google Scholar
  10. 10.
    Knöchel C, Alves G, Friedrichs B, et al. Treatment-resistant late-life depression: challenges and perspectives. Curr Neuropharmacol. 2015;13:577–91.CrossRefPubMedPubMedCentralGoogle Scholar
  11. 11.
    Saczynski JS, Beiser A, Seshadri S, et al. Depressive symptoms and risk of dementia. Neurology. 2010;75(1):35–41.CrossRefPubMedPubMedCentralGoogle Scholar
  12. 12.
    Byers AL, Yaffe K. Depression and risk of developing dementia. Nat Rev Neurol. 2011;7(6):323–31.CrossRefPubMedPubMedCentralGoogle Scholar
  13. 13.
    Angst J, Angst F, Stassen HH. Suicide risk in patients with major depressive disorder. J Clin Psychiatry. 1999;60(2):57–62.PubMedGoogle Scholar
  14. 14.
    Cole MG, Dendukuri N. Risk factors for depression among elderly community subjects: a systematic review and meta-analysis. Am J Psychiatry. 2003;160:1147–56.CrossRefPubMedGoogle Scholar
  15. 15.
    Fernandez-Pujals AM, Adams MJ, Thomson P, et al. Epidemiology and heritability of major depressive disorder, stratified by age of onset, sex and illness course in Generation Scotland: Scottish Family Health Study (GS: SFHS). PLoS ONE. 2015;10(11):e0142197.  https://doi.org/10.1371/journal.pone.0142197.CrossRefPubMedPubMedCentralGoogle Scholar
  16. 16.
    Chirita AL, Gheorman V, Bondari D, et al. Current understanding of the neurobiology of major depressive disorder. Romanian J Morphol Embryol. 2015;56(2):651–8.Google Scholar
  17. 17.
    Disabato BM, Sheline YI. Biological basis of late life depression. Curr Psychiatry Rep. 2012;14(4):273–9.CrossRefPubMedPubMedCentralGoogle Scholar
  18. 18.
    Shi Y, You J, Yuan Y, et al. Plasma BDNF and tPA are associated with late-onset geriatric depression. Psychiatry Clin Neurosci. 2010;64:249–54.Google Scholar
  19. 19.
    Hackett ML, Yapa C, Parag V, et al. Frequency of depression after stroke: a systematic review of observational studies. Stroke. 2005;36:1330–40.CrossRefPubMedGoogle Scholar
  20. 20.
    Choi NG, Kim J, Marti CN, et al. Late-life depression and cardiovascular disease burden: examination of reciprocal relationship. Am J Geriatr Psychiatry. 2014;22(12):1522–9.CrossRefPubMedPubMedCentralGoogle Scholar
  21. 21.
    Alexopoulos GS, Meyers BS, Young RC, et al. ‘Vascular depression’ hypothesis. Arch Gen Psychiatry. 1997;54(10):915–22.CrossRefPubMedGoogle Scholar
  22. 22.
    Brundin LC. Ascertaining whether suicides are caused by infections. JAMA Psychiatry. 2016;73(9):895–6.Google Scholar
  23. 23.
    Lund-Sorensen H, Benros ME, Madsen T, et al. A nationwide cohort study of the association between hospitalization with infection and risk of death by suicide. JAMA Psychiatry. 2016;73(9):912–9.Google Scholar
  24. 24.
    Hegeman JM, de Waal MWM, Comijs HC, et al. Depression in later life: a more somatic presentation? J Affect Disord. 2015;170:196–202.CrossRefPubMedGoogle Scholar
  25. 25.
    Fountoulakis KN, O’Hara R, Iacovides A, et al. Unipolar late-onset depression: a comprehensive review. Ann Gen Hosp Psychiatry. 2003;2(1):11.Google Scholar
  26. 26.
    Canadian Coalition for Seniors Mental Health. National guidelines for senior’s mental health—the assessment and treatment of depression. 2006. http://seniorspolicylens.ca/Root/Materials/Adobe%20Acrobat%20Materials/Guidelines_for_Depression.pdf. Accessed 30 Oct 2016.
  27. 27.
    McIntosh A. “Suicide rates in the elderly”. Seniors matter. http://seniorsmatter.com/senior-living/suicide-rates-in-the-elderly/. Accessed 10 Dec 2016.
  28. 28.
    Heisel MJ, Grek A, Moore SL, et al. National guidelines for seniors’ mental health: the assessment of suicide risk and prevention of suicide. Can J Geriatrics. 2006;9(2):S65–71.Google Scholar
  29. 29.
    Gelenberg AJ, Freeman MP, Markowitz JC, et al. Practice guideline for the treatment of patients with major depressive disorder, 3rd edition. American Psychiatric Association. 2010. https://psychiatryonline.org/pb/assets/raw/sitewide/practice_guidelines/guidelines/mdd.pdf. Accessed 30 Oct 2016.
  30. 30.
    Parikh SV, Quilty LC, Ravitz P, et al. Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 clinical guidelines for the management of adults with major depressive disorder: section 2. Psychological treatments. Can J Psychiatry. 2016;61(9):524–39.Google Scholar
  31. 31.
    Kennedy SH, Lam RW, McIntyre RS, et al. Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 clinical guidelines for the management of adults with major depressive disorder: section 3. Pharmacological treatments. Can J Psychiatry. 2016;61(9):540–60.Google Scholar
  32. 32.
    Wang SM, Han C, Lee SJ, et al. Second generation antipsychotics in the treatment of major depressive disorder: an update. Chonnam Med J. 2016;52:159–72.CrossRefPubMedPubMedCentralGoogle Scholar
  33. 33.
    Köhler O, Gasse C, Petersen L, et al. The effect of concomitant treatment with SSRIs and statins: a population-based study. Am J Psychiatry. 2016;173:807–15.CrossRefPubMedGoogle Scholar
  34. 34.
    Milev RV, Giacobbe P, Kennedy SH, et al. Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 clinical guidelines for the management of adults with major depressive disorder: section 4. Neurostimulation treatments. Can J Psychiatry. 2016;61(9):561–75.Google Scholar
  35. 35.
    Blumberger DM, Hsu JH, Daskalakis ZJ. A review of brain stimulation treatments for late-life depression. Curr Treat Options Psychiatry. 2015;2(4):413–21.CrossRefPubMedPubMedCentralGoogle Scholar
  36. 36.
    Ravindran AV, Balneaves LG, Faulkner G, et al. Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 clinical guidelines for the management of adults with major depressive disorder: section 5. Complementary and alternative medicine treatments. Can J Psychiatry. 2016;61(9):576–87.Google Scholar
  37. 37.
    Perera S, Eisen R, Bhatt M, et al. Light therapy for non-seasonal depression: systematic review and meta-analysis. Br J Psychiatry. 2016;2(2):116–26.Google Scholar
  38. 38.
    Murri MB, Amore M, Menchetti M, et al. Physical exercise for late-late major depression. Br J Psychiatry. 2015;207(3):235–42.CrossRefGoogle Scholar
  39. 39.
    Varteresian T, Lavretsky H. Natural products and supplements for geriatric depression and cognitive disorders: an evaluation of the research. Curr Psychiatry Rep. 2014;16(8):456.CrossRefPubMedPubMedCentralGoogle Scholar
  40. 40.
    Aizenstein HJ, Khalef A, Walker SE, et al. MRI predictors of treatment response in late-life depression. J Geriatr psychiatry Neurology. 2014;27(1):24–32.CrossRefGoogle Scholar
  41. 41.
    Ribeiz SRI, Duran F, Oliveira MC, et al. Structural brain changes as biomarkers and outcome predictors in patients with late-life depression: a cross-sectional and prospective study. PLoS ONE. 2013;8(11):e80049.  https://doi.org/10.1371/journal.pone.0080049.CrossRefPubMedPubMedCentralGoogle Scholar
  42. 42.
    Public Health Agency of Canada. Report on sexually transmitted infections in canada: 2012. http://phac-aspc.gc.ca/sti-its-surv-epi/rep-rap-2012/rep-rap-3-eng.php. Accessed 30 Oct 2016.
  43. 43.
    Schneider LS, Dagerman KS, Insel P. Risk of death with atypical antipsychotic drug treatment for dementia. JAMA. 2005;294(15):1934–43.CrossRefPubMedGoogle Scholar
  44. 44.
    Gareri P, Segura-Garcia C, Manfredi VGL, et al. Use of atypical antipsychotics in the elderly: a clinical review. Clin Interv Aging. 2014;9:1363–73.Google Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Authors and Affiliations

  1. 1.Department of Psychiatry and Behavioural SciencesMcMaster University, St. Joseph’s Healthcare HamiltonHamiltonCanada

Personalised recommendations